by The global Weight Loss Supplements market size is expected to be worth around US$ 120.6 billion by 2030, according to a new report by Vision Research Reports.
The global Weight Loss Supplements market size was valued at US$ 35.4 billion in 2020 and is anticipated to grow at a CAGR of 17.6% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38963
Table of Contents
Weight Loss Supplements Market Growth Factors
Rising cases of obesity across the globe coupled with increasing consumer awareness levels about following a healthier and fit lifestyle will drive the market. In addition, a rising number of fitness centers and gyms in several countries and increased awareness about the importance of weight loss supplements are projected to drive the market growth. Moreover, rising disposable income levels and improved accessibility & affordability of surgeries are propelling the market growth.
The rising cases of obesity and related health ailments, such as Cardiovascular Diseases (CVDs), diabetes, and hypertension, are expected to drive product demand.
Weight Loss Supplements Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 120.6 billion by 2030 |
| Growth Rate | CAGR of 17.6% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Ingredients, End user, Distribution Channel |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Glanbia PLC; GlaxoSmithKline PLC; Herbalife Nutrition Ltd; Abbott; Kellogg Company; Kraft Heinz Company; Amway Corporation; Nestle; PepsiCo; Ajinomoto Co. Inc. |
By Type Analysis
The powders segment accounted for the highest revenue share of 33.7%. The powdered formulation makes provision of higher quantities of supplement and has a longer shelf life with the easily regulated dosages as per individual requirement, which is a driving factor for this segment.
The pills type segment is expected to record the fastest CAGR over the forecast years. Arise in preference for weight loss supplements in pills formulation due to the easy availability of the same in chewable tablets sustained-release pills, and sublingual pills is contributing to the segment growth.
By Ingredient Analysis
The vitamins and minerals segment dominated the market with a revenue share of 58.0%, owing to the widespread consumption of vitamin- and mineral-based weight loss supplements.
Several vitamins- and mineral-based products comprise antioxidants, which prevent cell damage from structural changes as well as enhance an individual’s overall health and performance.
The natural extracts and botanicals segment is anticipated to register the fastest growth rate over the forecast years. The growing demand for organic and vegan supplements across the globe due to the rising environmental concerns is expected to positively impact the segment growth.
By Distribution Channel Analysis
The offline distribution channel segment accounted for the highest revenue share of 70.4%. The easy availability of weight loss supplements at retail pharmacies, drug stores, health & beauty stores, and department stores is contributing to the segment growth.
Offline stores are continuously involved in increasing the overall customer engagement and experience at the stores. Several health & beauty stores and department stores have introduced point-of-sale terminals to accelerate the checkout process.
The online distribution channel segment is expected to record the fastest CAGR over the forecast period. Online retailers offer lucrative discounts on product prices, which, in turn, drives sales through online channels.
The convenience offered by online distribution channels is positively impacting the segment growth. Furthermore, with the penetration of e-commerce, there is a gradual shift towards online distribution channels of supplements. The rise in self-directed consumers is also one of the key factors driving the segment growth.
By End-user Analysis
The 18 to 40 years end-user segment dominated the market with a revenue share of 61.6% owing to rapidly growing cases of obesity in this population segment. The growing need to maintain normal body weight and optimum physique is expected to drive the growth of this segment.
The growing awareness levels of the benefits and functioning of weight loss supplements are expected to drive the segment. As per the adults have claimed to have consumed weight-loss dietary supplements in their lifetime, with higher consumption recorded in female adults compared to males. The growing demand for appetite suppressants.
The under 18 years end-users segment is anticipated to record the fastest CAGR over the forecast period. Rising awareness levels among the consumers under this age group about the product benefits will drive the segment.
By Regional Analysis
Asia Pacific held the largest share of 46.0% of the overall revenue due to the high prevalence of obesity, growing disposable income, and rising health consciousness among consumers.
North America is anticipated to register the fastest CAGR over the forecast period owing to the alarming rise in obesity cases in the U.S. Growing sedentary lifestyle coupled with unhealthy dietary habits is leading to significant growth in the cases of obesity and related health issues.
Read also @ Endoscopy Operative Devices Market Size Hit US$ 20.7 Billion by 2030
Major Key Players Covered in The Weight Loss Supplements Market Report include
- Glanbia PLC
- GlaxoSmithKline PLC
- Herbalife Nutrition Ltd.
- Abbott
- Kellogg Company
- Nestle
- Kraft Heinz Company
- Amway Corp.
- PepsiCo
- Ajinomoto Co. Inc.
Weight Loss Supplements Market Segmentation
- By Type
- Liquid
- Powder
- Softgels
- Pills
- Others
- By Ingredient
- Vitamins & Minerals
- Amino Acids
- Natural Extracts/ Botanicals
- By End-user
- Under 18 years
- 18 to 40 years
- 40 to 50 years
- Above 50 years
- By Distribution Channel
- Offline Channel
- Online Channel
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Weight Loss Supplements Market Snapshot
Chapter 4. Weight Loss Supplements Market Variables and Scope
4.1. Introduction
4.2. Weight Loss Supplements Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Weight Loss Supplements Market Dynamics Analysis and Trends
5.1. Weight Loss Supplements Market Dynamics
5.1.1. Weight Loss Supplements Market Drivers
5.1.2. Weight Loss Supplements Market Restraints
5.1.3. Weight Loss Supplements Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Weight Loss Supplements Market Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Weight Loss Supplements Market, By Type
7.1. Weight Loss Supplements Market, by Type, 2021-2030
7.1.1. Liquid
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Powder
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Softgels
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Pills
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Weight Loss Supplements Market, By Ingredient
8.1. Weight Loss Supplements Market, by Ingredient, 2021-2030
8.1.1. Vitamins & Minerals
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Amino Acids
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Natural Extracts/ Botanicals
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Weight Loss Supplements Market, By Distribution Channel
9.1. Weight Loss Supplements Market, by Distribution Channel, 2021-2030
9.1.1. Offline Channel
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Online Channel
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Weight Loss Supplements Market, By End user
10.1. Weight Loss Supplements Market, by End user, 2021-2030
10.1.1. Under 18 years
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. 18 to 40 years
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. 40 to 50 years
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Above 50 years
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Weight Loss Supplements Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.4. Market Revenue and Forecast, by End user (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End user (2017-2030)
Chapter 12. Company Profiles
12.1. Glanbia PLC
12.1.1. Company Overview
12.1.2. Type Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline PLC
12.2.1. Company Overview
12.2.2. Type Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Herbalife Nutrition Ltd.
12.3.1. Company Overview
12.3.2. Type Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Type Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg Company
12.5.1. Company Overview
12.5.2. Type Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Nestle
12.6.1. Company Overview
12.6.2. Type Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Kraft Heinz Company
12.7.1. Company Overview
12.7.2. Type Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Amway Corp.
12.8.1. Company Overview
12.8.2. Type Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. PepsiCo
12.9.1. Company Overview
12.9.2. Type Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Ajinomoto Co. Inc.
12.10.1. Company Overview
12.10.2. Type Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38963
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
